10x Genomics, Inc. TXG

TXG Company Overview

10x Genomics, Inc. is a U.S.-based life sciences technology company focused on developing genomic analysis tools that enable researchers to study biology at high resolution and scale. The company operates primarily in the biotechnology, life sciences research, and genomics industries, with products designed for applications in single-cell analysis, spatial biology, and immune profiling. Its technologies are widely used by academic institutions, biopharmaceutical companies, and translational research organizations for research into cancer, immunology, neuroscience, infectious disease, and cell and gene therapy development.

The company’s principal revenue drivers include sales of instruments, consumables, and software associated with its genomics platforms, particularly the Chromium and Visium product families. Consumables represent a significant recurring revenue component due to repeat usage in research workflows. Founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness, 10x Genomics evolved from a focus on microfluidics-enabled single-cell sequencing into a broader spatial and multiomics platform company. The company has positioned itself as a leader in high-throughput single-cell genomics through proprietary barcoding, partitioning, and spatial transcriptomics technologies that support large-scale biological analysis.